Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$14.06$20.13
1-Month Range
Month up 0.0%
$19.31$19.31
Daily Price Range
Day down -1.3%
——
Volume
vs 19M avg
019M avg
Profile
Identity and capital structure
SectorUnclassified
IndustryCommon Stock
Market Cap$37.1B
Short % of Float—
Employees—
Sales$15,124M
Shares Outstanding1,921,768,446
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.kvue.com
Kenvue Inc — Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and othe….· via yahoo
Warnings
1 signal
Live
- Current ratio below 1 (0.95)
Scores
0–100 · higher is better except where noted · Insider Sent: directional buy ratio (excl. gifts/grants)
Value
91
Growth
77
Quality
70
Sentiment
60
Insider Sent.
—
Piotroski F
5
Altman Z
2.2
Consensus rating unavailable — no analyst coverage on file for KVUE.
Price targets unavailable — no 12-month targets on file for KVUE.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on KVUE, calculate Margin of Safety, and stress-test WACC discount hurdles.
RetrievedQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 1 warnings surfacedNov 11, 2026, 6:09 PM UTC